Source link : https://www.newshealth.biz/health-news/why-do-glp-1-drugs-stop-working-and-what-to-do-about-it/
There’s no question that glucagon-like peptide 1 (GLP-1) agonists represent a major advance in the treatment of obesity for patients with or without diabetes. In clinical trials, participants lost 15%-20% of their body weight, depending on the drug. But studies also have shown that once people stop taking these drugs — either by choice, because […]
Author : News Health
Publish date : 2024-01-12 12:15:32
Copyright for syndicated content belongs to the linked Source.